KINGSWAY SURGERY — All Prescriptions & Medications — Page 4
Practice Code: F81170 | CHELMSFORD, CM3 5QP
Showing results 151-200 of 596
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Topiramate | 268 | 21.0K | £2.9K | +50.8% ▲ |
| Carbamazepine | 267 | 26.5K | £1.9K | -10.0% ▼ |
| Tirzepatide | 267 | 380 | £35.4K | +37.5% ▲ |
| Lactulose | 261 | 118.1K | £1.1K | -20.7% ▼ |
| Quinine sulfate | 261 | 8,434 | £1.4K | -9.8% ▼ |
| Enalapril maleate | 256 | 14.0K | £599 | +42.5% ▲ |
| Zolpidem tartrate | 250 | 4,645 | £211 | +177.5% ▲ |
| Paroxetine hydrochloride | 248 | 10.6K | £528 | +32.9% ▲ |
| Prochlorperazine maleate | 241 | 9,078 | £640 | +19.2% ▲ |
| Azathioprine | 241 | 14.3K | £380 | +122.4% ▲ |
| Glyceryl trinitrate | 239 | 560 | £701 | +1.0% vs avg |
| Timolol and bimatoprost | 237 | 2,715 | £3.4K | +56.2% ▲ |
| Betahistine hydrochloride | 235 | 22.9K | £761 | -1.6% vs avg |
| Esomeprazole | 232 | 9,758 | £971 | -42.7% ▼ |
| Thiamine hydrochloride | 228 | 9,041 | £248 | -56.7% ▼ |
| Brinzolamide | 225 | 1,760 | £1.3K | +73.2% ▲ |
| 224 | 26.3K | £957 | +71.0% ▲ | |
| RtS 2-2.4 kcal/ml m/sk higher protein,higher energy(0913011) | 222 | 1.4M | £14.0K | +407.4% ▲ |
| Tiotropium bromide | 220 | 2,566 | £6.6K | -27.6% ▼ |
| Chloramphenicol | 216 | 1,644 | £911 | +88.6% ▲ |
| Clobetasol propionate | 216 | 9,965 | £812 | +58.3% ▲ |
| Irbesartan | 215 | 10.1K | £433 | -11.8% ▼ |
| Calcipotriol | 213 | 19.4K | £9.1K | +25.1% ▲ |
| Lorazepam | 207 | 8,926 | £3.2K | +45.2% ▲ |
| Tapentadol | 207 | 8,862 | £5.4K | +402.8% ▲ |
| Sacubitril/valsartan | 206 | 13.8K | £22.5K | -14.0% ▼ |
| Methylprednisolone acetate | 206 | 228 | £810 | +78.4% ▲ |
| Aripiprazole | 205 | 4,298 | £1.3K | -19.4% ▼ |
| Olanzapine | 204 | 5,988 | £704 | -44.9% ▼ |
| Estriol | 201 | 3,415 | £3.2K | -5.5% ▼ |
| Nystatin | 199 | 6,750 | £387 | +97.4% ▲ |
| Aciclovir | 198 | 8,373 | £399 | +33.1% ▲ |
| Biphasic insulin aspart | 197 | 1,650 | £9.8K | +94.0% ▲ |
| Hydrocortisone acetate | 193 | 6,015 | £1.1K | +192.3% ▲ |
| Clobetasone butyrate | 191 | 12.2K | £1.2K | -6.4% ▼ |
| Oxybutynin | 188 | 11.9K | £2.0K | -1.3% vs avg |
| 185 | 87.1K | £1.0K | -29.9% ▼ | |
| Insulin detemir | 179 | 1,230 | £10.3K | +128.6% ▲ |
| Travoprost | 179 | 623 | £838 | +279.9% ▲ |
| Cyclizine hydrochloride | 178 | 5,335 | £197 | +10.3% ▲ |
| Docusate sodium | 177 | 12.8K | £887 | -52.3% ▼ |
| Risedronate sodium | 177 | 964 | £267 | +45.9% ▲ |
| Semaglutide | 172 | 4,478 | £16.5K | -28.6% ▼ |
| Famotidine | 167 | 6,265 | £3.5K | -65.8% ▼ |
| Rizatriptan | 167 | 1,290 | £3.9K | +181.0% ▲ |
| Co-beneldopa (Benserazide/levodopa) | 166 | 22.6K | £1.5K | +9.8% ▲ |
| Hepatitis A | 164 | 164 | £3.2K | +116.0% ▲ |
| Lidocaine hydrochloride | 164 | 1,030 | £1.1K | -4.9% ▼ |
| Alginic acid compound preparations | 163 | 65.8K | £1.4K | -72.2% ▼ |
| Insulin Lispro | 163 | 1,172 | £7.6K | +113.1% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.